Diabetic patients present their providers with unique clinical challenges when dealing with prevention and treatment of infectious diseases. By the very nature of their diabetes, these patients are at much higher risk of complications from seemingly benign infections as well as increasingly susceptible to more resistant or invasive disease. Targeted prevention where possible, regular follow-up, and early, aggressive treatment are crucial to diabetic patients’ longevity and quality of life. This review will focus on key vaccine-preventable issues as well as management of common conditions such as urinary tract infection and skin and soft tissue infection often seen in diabetic patients.
TamirE. Treating the diabetic ulcer: practical approach and general concepts. Isr Med Assoc J. 2007;9:610–615.
3.
O’MearaSCullumNMajidM. Systematic Reviews of Wound Care Management: (3) Antimicrobial Agents for Chronic Wounds; (4) Diabetic Foot Ulceration. Review. Alton: Core Research; 2000.
4.
GilbertDNMoelleringRCEliopoulosGM. The Sanford Guide to Antimicrobial Therapy, 38th ed.Sperryville, VA: Antimicrobial Therapy Incorporated. 2008;14,30.
5.
FalagasMEMatthaiouDKVardakasKZ. Fluoroquinolones vs beta-lactams for empirical treatment of immunocompetent patients with skin and soft tissue infections: a meta-analysis of randomized controlled trials. Mayo Clin Proc. 2006;81:1553–1566.
6.
LaPlanteKLMersfelderTLWardKE. Prevalence of and risk factors for dysglycemia in patients receiving gatifloxacin and levofloxacin in an outpatient setting. Pharmacotherapy. 2008;28:82–89.
7.
SottoABouzigesNJourdanN. In vitro activity of tigecycline against strains isolated from diabetic foot ulcers. Pathol Biol. 2007;55:398–406.
8.
FoxmanBBarlowRD’ArcyH. Urinary tract infection: self-reported incidence and associated costs. Ann Epidemiol. 2000;10:509–515.
9.
StammWEHootonTM. Management of urinary tract infections in adults. NEJM. 1993;329:1328–1334.
10.
GuptaKSahmDFMayfieldD. Antimicrobial resistance among uropathogens that cause community-acquired urinary tract infections in women: a nationwide analysis. Clin Infect Dis. 2001;33:89–94.
11.
HuKKBoykoEJScholesD. Risk factors for urinary tract infections in postmenopausal women. Arch Intern Med. 2004;164:989–993.
12.
Infectious Diseases Society of America Web site. Available at:http://www.idsociety.org. Accessed August 1, 2008
13.
SmithSAPolandGA. The use of influenza and pneumococcal vaccines in people with diabetes (Technical Review). Diabetes Care. 2000;23:95–108.
14.
SmithSAPolandGA. Influenza and pneumococcal immunization in diabetes. Diabetes Care. 2004;27:s111–s113.
